New Delhi, April 23 -- The US Department of Justice and Drug Enforcement Administration (DEA) have announced a major change to how marijuana is treated under US law. The move follows an executive order by Donald Trump and could reshape medical use, research, and the cannabis industry.

Some marijuana products are now classified as less dangerous drugs.

This includes:

-FDA-approved cannabis-based medicines

-Medical marijuana regulated by state licences

These products are being moved to Schedule III under US drug laws, instead of stricter categories.

Drug schedules in the US rank substances by risk:

Schedule I: Highly dangerous, no accepted medical use (e.g. heroin, LSD)

Schedule III: Lower risk, accepted medical use (e.g. some paink...